Clinical trials
Completed Phase 3 Pulmonary Disease, Chronic Obstructive trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
386 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 9 |
| 2001 | 6 |
| 2002 | 25 |
| 2003 | 11 |
| 2004 | 5 |
| 2005 | 13 |
| 2006 | 17 |
| 2007 | 15 |
| 2008 | 14 |
| 2009 | 35 |
| 2010 | 22 |
| 2011 | 35 |
| 2012 | 37 |
| 2013 | 25 |
| 2014 | 24 |
| 2015 | 19 |
| 2016 | 13 |
| 2017 | 8 |
| 2018 | 2 |
| 2019 | 7 |
| 2020 | 6 |
| 2021 | 6 |
| 2022 | 7 |
| 2023 | 5 |
| 2024 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 386 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boehringer Ingelheim | 75 |
| GlaxoSmithKline | 58 |
| AstraZeneca | 54 |
| Novartis Pharmaceuticals | 41 |
| Pearl Therapeutics, Inc. | 16 |
| Chiesi Farmaceutici S.p.A. | 13 |
| Novartis | 12 |
| Sumitomo Pharma America, Inc. | 8 |
| Dey | 6 |
| National Heart, Lung, and Blood Institute (NHLBI) | 6 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pulmonary Disease, Chronic Obstructive | 386 |
| Emphysema | 20 |
| Bronchitis, Chronic | 18 |
| Lung Diseases | 14 |
| Lung Diseases, Obstructive | 13 |
| Dyspnea | 8 |
| Asthma | 7 |
| Bronchitis | 5 |
| Respiratory Tract Diseases | 5 |
| Bronchiolitis Obliterans Syndrome | 3 |
Trials
Showing 1 to 25 of 386. Each trial links to its page on Pharma Observatory.
286 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.